{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:52:48Z","timestamp":1792299168555,"version":"4.4.0"},"reference-count":42,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,11,18]],"date-time":"2005-11-18T00:00:00Z","timestamp":1132272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Rep Immunol"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:sec><jats:title>Problem<\/jats:title><jats:p>Recurrent spontaneous abortion associated with immunologic abnormalities has been termed immunologic abortion. Previously we showed that treatment with low\u2010dose intravenous immunoglobulin (IVIG) appears to be beneficial for older women with immunologic abortion. We now report the results of IVIG treatment in a larger group of women with this disorder.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method of study<\/jats:title><jats:p>A total of 99 women were prospectively evaluated for immunologic abortion, which was defined as three or more miscarriages and the presence of specific immunologic abnormalities. Prior to the next conception, patients were treated with IVIG at a dose of 0.2\u2003g\/kg. Once conception was achieved, IVIG treatment was continued on a monthly basis through 26\u201330\u2003weeks of pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The average age of the women was 37\u2003years (range: 28\u201349), and the average number of miscarriages was 3.8 (range: 3\u201312). Of the 99 women, 72 received initial IVIG treatment, and 50 subsequently became pregnant. Of these women, 42 (84%) had a successful term pregnancy. Of the 27 women who refused IVIG therapy, 20 became pregnant and 18 (90%) miscarried. The difference in pregnancy success rate between the IVIG\u2010treated and untreated groups was significant (<jats:italic>P<\/jats:italic>\u2003=\u20030.001). Four women had mild allergic reactions during IVIG infusion, and these reactions resolved when the IVIG brand was changed. Fetal abnormalities were not observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We conclude that low\u2010dose IVIG therapy is safe and effective for older women with immunologic abortion.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1600-0897.2005.00335.x","type":"journal-article","created":{"date-parts":[[2005,11,18]],"date-time":"2005-11-18T23:16:37Z","timestamp":1132355797000},"page":"390-396","source":"Crossref","is-referenced-by-count":19,"title":["Update on Treatment of Immunologic Abortion with Low\u2010dose Intravenous Immunoglobulin"],"prefix":"10.1111","volume":"54","author":[{"given":"Raphael B.","family":"Stricker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward E.","family":"Winger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,11,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1998.tb00339.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1998.tb00338.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1998.tb00337.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)58170-9"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)05291-9"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/jama.1985.03350460078025","article-title":"IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters","volume":"253","author":"Gleicher N","year":"1985","journal-title":"JAMA"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)90612-B"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/jama.1990.03450110068029","article-title":"Detection of at\u2010risk pregnancy by means of highly sensitive assays for thyroid antibodies","volume":"264","author":"Stagnaro\u2010Green A","year":"1990","journal-title":"JAMA"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)60491-0"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-199409000-00025"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1995.tb01136.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520480053039"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.4049\/jimmunol.156.10.4027","article-title":"Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion","volume":"156","author":"Lachapelle MH","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.4049\/jimmunol.158.10.4886","article-title":"Early embryo loss is associated with the prior expression of macrophage activation markers in the decidua","volume":"158","author":"Haddad EK","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707173370303"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.8.3069"},{"key":"e_1_2_6_18_2","first-page":"630","article-title":"Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies","volume":"75","author":"Rosove MH","year":"1990","journal-title":"Obstet Gynecol"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)70610-5"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349609047090"},{"key":"e_1_2_6_21_2","first-page":"368","article-title":"Pregnancy\u2010related death associated with heparin and aspirin treatment for infertility, 1996","volume":"47","author":"CDC","year":"1998","journal-title":"MMWR"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707173370302"},{"key":"e_1_2_6_23_2","first-page":"854","article-title":"Immunization as therapy for recurrent spontaneous abortion: a review and meta\u2010analysis","volume":"82","author":"Fraser EJ","year":"1993","journal-title":"Obstet Gynecol"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1027372409361"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1996.tb00493.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1996.tb00168.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a138435"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1994.tb13584.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a135769"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1529-1049(02)00046-6"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)22023-X"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/2006"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(98)01393-0"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1994.tb01122.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1996.tb00496.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1996.tb00495.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1994.1091"},{"key":"e_1_2_6_38_2","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.161.7.3781","article-title":"Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway","volume":"161","author":"Prasad NKA","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_6_39_2","first-page":"901","article-title":"Reemergence of sucrose nephropathy: acute renal failure caused by high\u2010dose intravenous immune globulin therapy","volume":"93","author":"Zhang R","year":"2000","journal-title":"South Med J"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422507"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422506"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.7.821"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)01950-1"}],"container-title":["American Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0897.2005.00335.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0897.2005.00335.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0897.2005.00335.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:18:27Z","timestamp":1695773907000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0897.2005.00335.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,18]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1600-0897.2005.00335.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0897.2005.00335.x","archive":["Portico"],"relation":{},"ISSN":["1046-7408","1600-0897"],"issn-type":[{"value":"1046-7408","type":"print"},{"value":"1600-0897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,18]]}}}